CRI vs HBI

For growth investors, Carter's, Inc.

(CRI) is the stronger pick with 1. 9% revenue growth year-over-year, versus -3. 6% for Hanesbrands Inc. (HBI). Carter's, Inc. (CRI) offers the better valuation at 14. 4x trailing P/E (10. 8x forward), making it the more compelling value choice. Analysts rate Carter's, Inc. (CRI) a "Buy" — based on 24 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, Hanesbrands Inc.

is actually cheaper at 9. 8x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Carter's, Inc.

(CRI) delivered a total return of -54. 3%, compared to -65. 7% for Hanesbrands Inc. (HBI). Over 10 years, the gap is even starker: CRI returned -47. 0% versus HBI's -62. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Carter's, Inc.

(CRI) is the lower-risk stock at 1. 34β versus Hanesbrands Inc. 's 1. 72β — meaning HBI is approximately 28% more volatile than CRI relative to the S&P 500. On balance sheet safety, Carter's, Inc. (CRI) carries a lower debt/equity ratio of 131% versus 75% for Hanesbrands Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Carter's, Inc.

(CRI) is pulling ahead at 1. 9% versus -3. 6% for Hanesbrands Inc. (HBI). On earnings-per-share growth, the picture is similar: Carter's, Inc. grew EPS -49. 4% year-over-year, compared to -1698. 4% for Hanesbrands Inc.. Over a 3-year CAGR, CRI leads at -3. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Carter's, Inc.

(CRI) is the more profitable company, earning 3. 2% net margin versus -9. 1% for Hanesbrands Inc. — meaning it keeps 3. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HBI leads at 5. 3% versus 5. 0% for CRI. At the gross margin level — before operating expenses — CRI leads at 45. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Hanesbrands Inc.

(HBI) trades at 9. 8x forward P/E versus 10. 8x for Carter's, Inc. — 1. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HBI: 12. 1% to $7. 25.

In this comparison, CRI (4.

3% yield) pays a dividend. HBI does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Carter's, Inc.

(CRI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (4. 3% yield). Hanesbrands Inc. (HBI) carries a higher beta of 1. 72 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CRI: -47. 0%, HBI: -62. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Consumer Cyclical sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: CRI is a small-cap deep-value stock; HBI is a small-cap quality compounder stock. CRI pays a dividend while HBI does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.